Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001213900-22-008485
Filing Date
2022-02-18
Accepted
2022-02-18 16:30:19
Documents
1

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO SCHEDULE 13D ea155932-13da1holubiak_citi.htm SC 13D/A 40787
  Complete submission text file 0001213900-22-008485.txt   42259
Mailing Address C/O CITIUS PHARMACEUTICALS, INC. 63 GREAT ROAD MAYNARD MA 01754
Business Address
HOLUBIAK MYRON Z (Filed by) CIK: 0001199080 (see all company filings)

Type: SC 13D/A

Mailing Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016
Business Address 11 COMMERCE DRIVE 1ST FLOOR CRANFORD NJ 07016 (908) 967-6676
Citius Pharmaceuticals, Inc. (Subject) CIK: 0001506251 (see all company filings)

EIN.: 273425913 | State of Incorp.: NV | Fiscal Year End: 0930
Type: SC 13D/A | Act: 34 | File No.: 005-90253 | Film No.: 22653235
SIC: 2834 Pharmaceutical Preparations